Keyphrases
Type I Diabetes
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Urine Proteome
100%
Estimated Glomerular Filtration Rate Decline
100%
Cathepsin D
100%
Tubular Injury
22%
Renal Tubular Epithelial Cells
22%
Human Cohort
22%
Epithelial Cell Culture
22%
Validation Set
22%
Odds Ratio
11%
Control Subjects
11%
Clinical Variables
11%
Meta-analysis
11%
Kidney
11%
Adjusted Model
11%
Albuminuria
11%
Kidney Disease
11%
Advanced Glycation End Products
11%
Small Interfering RNA (siRNA)
11%
Tubulointerstitial
11%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
11%
Laboratory Parameters
11%
Dipeptide
11%
Diabetic Kidney Disease
11%
Significant Protein
11%
Tubular Markers
11%
Urinary Protein
11%
D-protein
11%
Inflammatory Injury
11%
Fractional Volume
11%
Medicine and Dentistry
Biological Marker
100%
Insulin Dependent Diabetes Mellitus
100%
Glomerular Filtration Rate
100%
Urinary System
100%
Proteomics
100%
Cathepsin D
100%
Injury
33%
Epithelial Cell
22%
Cell Culture
22%
Cohort Analysis
11%
Meta-Analysis
11%
Odds Ratio
11%
Nephropathy
11%
Case-Control Study
11%
Albuminuria
11%
Diabetic Nephropathy
11%
Research Design
11%
Advanced Glycation End-Product
11%
Small Interfering RNA
11%
Liquid Chromatography-Mass Spectrometry
11%
Bovine Serum Albumin
11%
Peptides and Proteins
11%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Dependent Diabetes Mellitus
100%
Biological Marker
100%
Cathepsin D
100%
Injury
33%
Mouse
22%
Cell Culture
22%
Cohort Study
11%
Case-Control Study
11%
Albuminuria
11%
Kidney Disease
11%
Diabetic Nephropathy
11%
Advanced Glycation End Product
11%
Small Interfering RNA
11%
Bovine Serum Albumin
11%
Peptides and Proteins
11%
Biochemistry, Genetics and Molecular Biology
Proteomics
100%
Glomerulus Filtration
100%
Cathepsin D
100%
Mouse
22%
Cell Culture
22%
Cohort Study
11%
Case-Control Study
11%
Protein Urine Level
11%
Liquid Chromatography-Mass Spectrometry
11%
Small Interfering RNA
11%
Advanced Glycation End-Product
11%
Bovine Serum Albumin
11%